Shares of Joint Corp (NASDAQ:JYNT) have been given an average rating of “Buy” by the nine analysts that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokers that have issued a report on the stock in the last year is $25.50.
Several research analysts have issued reports on JYNT shares. TheStreet lowered Joint from a “b-” rating to a “c” rating in a research note on Monday, January 6th. Zacks Investment Research upgraded Joint from a “hold” rating to a “strong-buy” rating and set a $18.00 target price for the company in a research note on Tuesday, January 14th. Maxim Group restated a “buy” rating and issued a $25.00 target price on shares of Joint in a research note on Friday, November 8th. ValuEngine upgraded Joint from a “sell” rating to a “hold” rating in a research note on Wednesday, January 29th. Finally, BidaskClub lowered Joint from a “buy” rating to a “hold” rating in a research note on Saturday, December 7th.
Joint stock traded down $0.01 during mid-day trading on Friday, hitting $15.34. 52,900 shares of the company were exchanged, compared to its average volume of 91,505. The company has a quick ratio of 0.84, a current ratio of 0.84 and a debt-to-equity ratio of 3.11. The business has a fifty day moving average of $16.28 and a 200 day moving average of $17.55. Joint has a 1-year low of $10.61 and a 1-year high of $21.80. The company has a market capitalization of $220.28 million, a PE ratio of 76.70 and a beta of 0.94.
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and the sale of regional developer rights. As of March 07, 2019, the company operated 450 clinics in the United States.
Read More: How do investors use RSI to grade stocks?
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.